Clinical trials
Enrolling by invitation Phase 3 trials in Austria
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
8 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2019 | 2 |
| 2021 | 1 |
| 2022 | 1 |
| 2023 | 2 |
| 2024 | 1 |
| 2025 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Enrolling by invitation | 8 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Alnylam Pharmaceuticals | 1 |
| Ionis Pharmaceuticals, Inc. | 1 |
| Pharvaris Netherlands B.V. | 1 |
| Rigel Pharmaceuticals | 1 |
| United Therapeutics | 1 |
| Viatris Innovation GmbH | 1 |
| Xenon Pharmaceuticals Inc. | 1 |
| argenx | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Amyloidosis | 2 |
| Angioedemas, Hereditary | 1 |
| Cardiomyopathies | 1 |
| Cardiovascular Diseases | 1 |
| Connective Tissue Diseases | 1 |
| Dermatomyositis | 1 |
| Epilepsies, Partial | 1 |
| Epilepsy | 1 |
| Familial Primary Pulmonary Hypertension | 1 |
| Hypertension | 1 |
Trials
Showing 1 to 8 of 8. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.